Tumour-associated macrophages drive stromal cell-dependent collagen crosslinking and stiffening to promote breast cancer aggression
2020 · Nature Materials · 298 citations
https://doi.org/10.1038/s41563-020-00849-5
P
Peter Kabos
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
336
Papers
4.2K
Citations
37
h-index
71
i10-index
Peter Kabos is an academic researcher from University of Colorado Hospital. The author has contributed to research in topics: Advanced Breast Cancer Therapies & HER2/EGFR in Cancer Research & Estrogen and related hormone effects. The author has an h-index of 37, co-authored 286 publications.
ORCID: 0000-0003-1500-471XPapers by this author
worksPatient-derived luminal breast cancer xenografts retain hormone receptor heterogeneity and help define unique estrogen-dependent gene signatures
2012 · Breast Cancer Research and Treatment · 140 citations
https://doi.org/10.1007/s10549-012-2164-8
Phase I Study of Elacestrant (RAD1901), a Novel Selective Estrogen Receptor Degrader, in ER-Positive, HER2-Negative Advanced Breast Cancer
2021 · Journal of Clinical Oncology · 107 citations
https://doi.org/10.1200/jco.20.02272
Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a
2014 · Oncogene · 73 citations
https://doi.org/10.1038/onc.2014.298
A phase II clinical trial of the Aurora and angiogenic kinase inhibitor ENMD-2076 for previously treated, advanced, or metastatic triple-negative breast cancer
2018 · Breast Cancer Research · 68 citations
https://doi.org/10.1186/s13058-018-1014-y
A phase I dose escalation and expansion trial of the next-generation oral SERD camizestrant in women with ER-positive, HER2-negative advanced breast cancer: SERENA-1 monotherapy results
2024 · Annals of Oncology · 57 citations
https://doi.org/10.1016/j.annonc.2024.04.012
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat